Careers  |  Sign In  |  Register

Breakthrough Device Applies Pinpoint Neurostimulation for Epilepsy Patients

Just approved by the FDA, a neurostimulator, “called the RNS System, aims to reduce seizures and to improve the lives of an estimated 400,000 Americans whose epilepsy cannot be treated with drugs or brain surgery, according to an article in The New York Times.” As a pioneer in a “new generation” of epilepsy therapy, Dr. Dileep R. Nair, head of adult epilepsy at the Cleveland Clinic and an investigator in the pivotal trial for NeuroPace’s RNS explains, “It’s delivering local therapy. It’s not taking tissue out; the brain is left intact. And it’s unlike a drug, which is a shotgun approach.”

Read it in The New York Times.